{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:31Z","timestamp":1780426891526,"version":"3.54.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Toxic epidermal necrolysis is a life-threatening disease. Over 95% of toxic epidermal necrolysis cases are caused by drugs, presenting as hemorrhagic erythema, blisters, and extensive epidermal detachment on the skin and mucous membranes. It is usually accompanied by multiple system damage. According to the size of the exfoliated area, toxic epidermal necrolysis is classified as severe (exfoliation area &gt;30% of body surface area).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 78-year-old female patient was admitted to our Department of Medical Oncology due to \u201cafter pancreatic cancer surgery for &gt;9 months, discovery of liver metastasis for &gt;1 months, multiple oral ulcers accompanied by multiple rashes throughout the body, with large red exfoliative maculopapule on the hands and feet for 5 days.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Postoperative status of pancreatic cancer, liver metastasis, and toxic epidermal necrolysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>After discontinuing anlotinib, the skin symptoms did not subside. Therefore, structured skin care was started.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The skin symptoms was resolved after starting structured skin care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>In this case, there was only 1 patient, and the nursing care was relatively limited. The effect needs further verification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044955","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:01:38Z","timestamp":1759248098000},"page":"e44955","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Structured skin care for a patient with toxic epidermal necrolysis caused by anlotinib: Case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4405-9217","authenticated-orcid":false,"given":"Jinjin","family":"Shao","sequence":"first","affiliation":[{"name":"Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiu","family":"Sun","sequence":"additional","affiliation":[{"name":"Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Yao","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gene.2018.02.026","article-title":"Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFR\u03b2 and FGFR1.","volume":"654","author":"Lin","year":"2018","journal-title":"Gene"},{"key":"R2-20260602","first-page":"3102","article-title":"Expert consensus on off-label use of anlotinib.","volume":"38","author":"Ge","year":"2021","journal-title":"Chin J Mod Appl Pharm"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/wound.2019.0977","article-title":"Toxic epidermal necrolysis and Steven\u2013Johnson syndrome: a comprehensive review.","volume":"9","author":"Charlton","year":"2020","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"R4-20260602","first-page":"2017","article-title":"Practical guidelines for cancer symptom management in China\u2014skin reactions.","volume":"34","author":"Zhang","year":"2019","journal-title":"J Nurses Train"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.2147\/OTT.S205674","article-title":"The efficacy and safety of anlotinib treatment for advanced lung cancer.","volume":"12","author":"Shao","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.ASW.0000828972.70137.8a","article-title":"A structured skin care protocol for preventing and treating incontinence-associated dermatitis in critically ill patients.","volume":"35","author":"Zhang","year":"2022","journal-title":"Adv Skin Wound Care"},{"key":"R8-20260602","first-page":"943","article-title":"Progress in diagnosis and treatment of skin diseases related to tumor-targeted drugs and immune checkpoint inhibitors.","volume":"28","author":"Xu","year":"2021","journal-title":"Chin J Clin Med"},{"key":"R9-20260602","first-page":"1061","article-title":"Evidence summary for prevention and management of the skin adverse reactions in patients with targeted tumor therapy.","volume":"57","author":"Hu","year":"2022","journal-title":"Chin J Nurs"},{"key":"R10-20260602","first-page":"68","article-title":"Prevention and care of hand-foot syndrome caused by camrelizumab combined with apatinib mesylate.","volume":"21","author":"Yu","year":"2022","journal-title":"J Nurs Rehabil"},{"key":"R11-20260602","first-page":"1515","article-title":"Observation on the efficacy of wet healing concept in patients with acute radiation skin injury.","volume":"34","author":"Zhu","year":"2019","journal-title":"J Nurses Train"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.annonc.2020.11.005","article-title":"Prevention and management of dermatological toxicities related to anticancer agents: ESMO clinical practice guidelines.","volume":"32","author":"Lacouture","year":"2021","journal-title":"Ann Oncol"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4081\/oncol.2020.442","article-title":"Management of cytotoxic chemotherapy-induced hand-foot syndrome.","volume":"14","author":"Kwakman","year":"2020","journal-title":"Oncol Rev"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/nicc.12475","article-title":"Enteral nutrition in critically ill adults: literature review of protocols.","volume":"25","author":"Jordan","year":"2020","journal-title":"Nurs Crit Care"},{"key":"R15-20260602","first-page":"718","article-title":"Interpretation of guideline for clinical application of parenteral and enteral nutrition in adults patients in China (2023 edition).","volume":"10","author":"Zhang","year":"2023","journal-title":"Electron J Metab Nutr Cancer"},{"key":"R16-20260602","first-page":"1868","article-title":"Best evidence summary for prevention and management of enteral feeding intolerance in critically ill patients.","volume":"54","author":"Mi","year":"2019","journal-title":"Chin J Nurs"},{"key":"R17-20260602","first-page":"26","article-title":"Application of ice saline wash in nursing oral pain caused by radiotherapy in patients with nasopharyngeal carcinoma.","volume":"27","author":"Xu","year":"2021","journal-title":"J Qilu Nurs"},{"key":"R18-20260602","first-page":"715","article-title":"Breast cancer patients with chemotherapy-induced hand-foot syndrome: a qualitative study of symptom experience.","volume":"19","author":"Chen","year":"2019","journal-title":"J Nurs Adm"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:01:52Z","timestamp":1780423312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":17,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044955","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}